Preparation of Monolithic Imprinted Stationary Phase for Clenbuterol by In Situ Polymerization and Application in Biological Samples Pretreatment
Preparation of Monolithic Imprinted Stationary Phase for Clenbuterol by In Situ Polymerization and Application in Biological Samples Pretreatment
复制标题
原位聚合制备克伦特罗整体印迹固定相及其在生物样品前处理中的应用
DOI:
10.1007/s10337-011-2129-9
复制
发表时间:
2011-11-01
期刊:
影响因子:
1.7
通讯作者:
Chang, Chun
中科院分区:
文献类型:
--
作者:
Luo, Yifen;Huang, Ping;Chang, Chun
A clenbuterol (CLB) molecule-imprinted monolithic stationary phase (MIMSP) with specific recognition for CLB and some other beta(2)-adrenergic receptor agonists was prepared by in situ polymerization technique utilizing methacrylic acid as a functional monomer, ethylene glycol dimethacrylate (EDMA) as a cross-linking reagent, and low polar solvents (toluene and dodecanol) as porogenic solvents. The optimal polymerization conditions were as follows: the molar ratio of template: monomer: initiator was 5:20:1, EDMA was 85% (v/v) in the total volume of monomer and EDMA, and toluene was 18% (v/v) in the total mixed porogen. The selectivity of the stationary phase for CLB and other beta(2)-adrenergic receptor agonists was evaluated by high performance liquid chromatography. Scatchard analysis was employed to explore the recognition mechanism. Then the CLB-MIMSP was used as a solid phase extraction (SPE) stationary phase for concentration and purification of CLB from pig liver samples. The results showed that the obtained CLB-MIMSP possessed high selectivity towards CLB and moderate selectivity towards some other beta(2)-adrenergic receptor agonists with characteristics of easy-made. The limit of detection was 10 ng g(-1), and recoveries of CLB were 99.16-113.06% with RSD 4.55-11.81% for the spiked pig liver samples. The CLB-MIMSP could be a promising SPE absorbent in CLB biological sample pretreatment.